Skip to main content

Advertisement

Log in

Bacteremia and respiratory involvement byAlcaligenes xylosoxidans in patients infected with the human immunodeficiency virus

  • Notes
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

Seven cases ofAlcaligenes xylosoxidans bacteremia and/or respiratory disease in patients infected with the human immunodeficiency virus (HIV) are described. Reported only thrice previously in this setting, these bacterial complications occurred during different phases of HIV infection and were associated with leukopenia-neutropenia in four patients and a central vascular catheter in two. Although the majority of cases were diagnosed after day 3 of hospitalization, a distinct source of infection was never identified. In four patients with advanced underlying disease, a polymicrobial infection was present. In vitro resistance to aminoglycosides, first-generation cephalosporins, and aztreonam was identified, but treatment with fluoroquinolones, piperacillin, or an aminoglycoside in combination with either ceftazidime or pefloxacin was successful in all cases. The relevance ofAlcaligenes xylosoxidans and related species of gramnegative non-glucose fermenting bacilli as opportunistic pathogens in the immunocompromised host and in the setting of HIV infection is briefly reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Mandell WF, Garvery GJ, Neu HC:Alcaligenes xylosoxidans bacteraemia. Reviews of Infectious Diseases 1987, 9: 1001–1005.

    PubMed  Google Scholar 

  2. McGann KA, Provencher M, Hoegg C, Talbot GH:Achromobacter xylosoxidans bacteremia. Infection Control and Hospital Epidemiology 1990, 11: 539–541.

    PubMed  Google Scholar 

  3. Hearn YR, Gander RM:Achromobacter xylosoxidans. An unusual neonatal pathogen. American Journal of Clinical Pathology 1991, 96: 211–214.

    PubMed  Google Scholar 

  4. Roilides E, Mueller BU, Letterio JJ, Butler K, Pizzo PA:Agrobacterium radiobacter bacteremia in a child with human immunodeficiency virus infection. Pediatric Infectious Disease Journal 1991, 10: 337–338.

    PubMed  Google Scholar 

  5. Legrand C, Anaissie E: Bacteremia due toAchromobacter xylosoxidans in patients with cancer. Clinical Infectious Diseases 1992, 14: 479–484.

    PubMed  Google Scholar 

  6. Cieslak TJ, Robb ML, Drabick CJ, Fischer GW: Catheter-associated sepsis caused byOchrobactrum anthropi: report of a case and review of related nonfermentative bacteria. Clinical Infectious Diseases 1992, 14: 902–907.

    PubMed  Google Scholar 

  7. Gransden WR, Eykyn SJ: Seven cases of bacteremia due toOchrobactrum anthropi. Clinical Infectious Diseases 1992, 15: 1068–1069.

    PubMed  Google Scholar 

  8. Hulse M, Johnson S, Ferrieri P:Agrobacterium infections in humans: experience at one hospital and review. Clinical Infectious Diseases 1993, 16: 112–117.

    PubMed  Google Scholar 

  9. Boukadida J, Monastiri K, Snoussi N, Jeddi M, Berche P: Nosocomial neonatal meningitis byAlcaligenes xylosoxidans transmitted by aqueous eosin. Pediatric Infectious Disease Journal 1993, 12: 696–697.

    PubMed  Google Scholar 

  10. Kern WW, Oethinger M, Kaufhold A, Rozdzinski E, Marre R:Ochrobactrum anthropi bacteremia: report of four cases and short review. Infection 1993, 21: 306–310.

    PubMed  Google Scholar 

  11. Dupont M, Winnock S, Rogues AM, Janvier G, DeBarbeyrac B, Saric J:Achromobacter xylosoxidans (Alcaligenes xylosoxidans subspeciesxylosoxidans) bacteremia after liver transplantation. Intensive Care Medicine 1993, 19: 480.

    PubMed  Google Scholar 

  12. Cieslak TJ, Raszka WV: Catheter-associated sepsis due toAlcaligenes xylosoxidans in a child with AIDS. Clinical Infectious Diseases 1993, 16: 592–593.

    PubMed  Google Scholar 

  13. Gradon JD, Mayrer AR, Hayes J: Pulmonary abscess associated withAlcaligenes xylosoxidans in a patient with AIDS. Clinical Infectious Diseases 1993, 17: 1071–1072.

    PubMed  Google Scholar 

  14. Taylor P, Fischbein L: Prosthetic knee infection due toAchromobacter xylosoxidans. Journal of Rheumatology 1992, 19: 992–993.

    PubMed  Google Scholar 

  15. Ezzedine H, Mourad M, Van Ossel C, Logghe C, Squifflet JP, Renault F, Wauters G, Gigi J, Wilmotte L, Haxhe JJ: An outbreak ofOchrobactrum anthropi bacteraemia in five organ transplant patients. Journal of Hospital Infection 1994, 27: 35–42.

    PubMed  Google Scholar 

  16. Alnor D, Frimodt-Moller N, Espersen F, Fredicksen W: Infections with the unusual human pathogensAgrobacterium species andOchrobactrum anthropi. Clinical Infectious Diseases 1994, 18: 914–920.

    PubMed  Google Scholar 

  17. Hoffkes HG, Schmid EN: Nosocomial infection byAlcaligenes xylosoxidans in neutropenic patients. Presse Medicale 1995, 24: 1180.

    Google Scholar 

  18. Bénaoudia F, François M, Brahimi N, Narcy P, Bingen E:Alcaligenes xylosoxidans-associated infection in an infant with cholesteatoma. Pediatric Infectious Disease Journal 1995, 14: 637–638.

    PubMed  Google Scholar 

  19. Ramos JM, Fernandez-Roblas R, Garcia Ruiz P, Soriano F: Meningitis caused byAlcaligenes (Achromobacter) xylosoxidans associated with epidural catheter. Infection 1995, 23: 395–396.

    PubMed  Google Scholar 

  20. Haditsch M, Binder L, Tschurtschenthaler G, Watschinger R, Zauner G, Mittermayer H: Bacteremia caused byOchrobactrum anthropi in an immunocompromised child. Infection 1994, 22: 291–292.

    PubMed  Google Scholar 

  21. Mastroianni A, Coronado O, Nanetti A, Manfredi R, Chiodo F:Agrobacterium radiobacter pneumonia in a patient with HIV infection. European Journal of Clinical Microbiology & Infectious Diseases 1996, 15: 960–963.

    Google Scholar 

  22. Mofredj A, Baraka D: Infection àAlcaligenes denitrificans subsp.xylosoxidans chez une patiente insuffisante respiratoire chronique corticodependante. Presse Medicale 1996, 25: 306.

    Google Scholar 

  23. Wintermeyer SM, Nahata MC:Alcaligenes xylosoxidans in children with chronic otorrhea. Otolaryngology — Head and Neck Surgery 1996, 114: 332–334.

    PubMed  Google Scholar 

  24. Knippschild M, Schmid EN, Uppenkamp M, König E, Meusers P, Brittinger G, Hoffkes HG: Infection byAlcaligenes xylosoxidans subsp.xylosoxidans in neutropenic patients. Oncology 1996, 53: 258–262.

    PubMed  Google Scholar 

  25. Chang HJ, Christenson JC, Pavia AT, Bobrin BD, Bland LA, Carson LA, Arduino MJ, Verma P, Aguero SM, Carroll K, Jenkins E, Daly JA, Woods ML, Jarvis WR:Ochrobactrum anthropi meningitis in pediatric pericardial allograft transplant recipients. Journal of Infectious Diseases 1996, 173: 656–660.

    PubMed  Google Scholar 

  26. Martino R, Martinez C, Pericas R, Salazar R, Sola C, Brunet S, Sureda A, Domingo Albos A: Bacteremia due to glucose non-fermenting gram-negative bacilli in patients with hematological neoplasias and solid tumors. European Journal of Clinical Microbiology & Infectious Diseases 1996, 15: 610–615.

    Google Scholar 

  27. Duggan JM, Goldstein SJ, Chenowetz CE, Kauffman CA, Bradley SF:Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature. Clinical Infectious Diseases 1996, 23: 569–676.

    PubMed  Google Scholar 

  28. Cheron M, Abachin E, Guerot E, El Bez M, Simonet M: Investigation of hospital-acquired infections due toAlcaligenes denitrificans subsp.xylosoxidans by DNA restriction fragment length polymorphism. Journal of Clinical Microbiology 1994, 32: 1023–1026.

    PubMed  Google Scholar 

  29. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A6, NCCLS, Villanova, PA, 1997, 13: 1–26.

    Google Scholar 

  30. Bergogne-Berezin E, Decre D, Joly-Guillou ML: Opportunistic nosocomial multiply resistant bacterial infections. Their treatment and prevention. Journal of Antimicrobial Chemotherapy 1993, 32, Supplement A: 39–47.

    PubMed  Google Scholar 

  31. Arpi M, Renneberg J, Andersen HK, Nielsen B, Larsen SO: Bacteremia at a Danish university hospital during a twenty-five-year period (1968–1992). Scandinavian Journal of Infectious Diseases 1995, 27: 245–251.

    PubMed  Google Scholar 

  32. Vu Thien H, Moissenet D, Valcin M, Dulot C, Tournier G, Garbarg-Chenon A: Molecular epidemiology ofBurkholderia cepacia, Stenotrophomonas maltophilia, andAlcaligenes xylosoxidans in a cystic fibrosis center. European Journal of Clinical Microbiology & Infectious Diseases 1996, 15: 876–879.

    Google Scholar 

  33. Bernard E, Carles M, Pradier C, Ozouf N, Dellamonica P: Septicémies communautaires et nosocomiales chez le patient infecté par le virus de l'immunodéficience humaine. Presse Medicale 1996, 25: 746–750.

    Google Scholar 

  34. Kovacs A, Leaf HL, Simberkoff MS: Bacterial infections. Medical Clinics of North America 1997, 81: 319–343.

    PubMed  Google Scholar 

  35. Rolston K, Messer M: Thein vitro susceptibility ofAlcaligenes denitrificans subsp.xylosoxidans to 40 antimicrobial agents. Journal of Antimicrobial Chemotherapy 1990, 26: 857–860.

    PubMed  Google Scholar 

  36. Glupczynski Y, Hansen W, Freney J, Yourassonisky E:In vitro susceptibility ofAlcaligenes denitrificans subsp.xylosoxidans to 24 antimicrobial agents. Antimicrobial Agents and Chemotherapy 1988, 32: 276–278.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Manfredi, R., Nanetti, A., Ferri, M. et al. Bacteremia and respiratory involvement byAlcaligenes xylosoxidans in patients infected with the human immunodeficiency virus. Eur. J. Clin. Microbiol. Infect. Dis. 16, 933–938 (1997). https://doi.org/10.1007/BF01700563

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01700563

Keywords

Navigation